UNSPSC 51291707: Isamoltan

This classification denotes an anxiolytic with the molecular formula C16H22N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2TP37O5J17, chemically known as 2-propanol, 1-((1-methylethyl)amino)-3-(2-(1h-pyrrol-1-yl)phenoxy)- but generally known as isamoltan, which bears US NIH Compound Identifier 127404. European Medicines Agency schedules Isamoltan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08304MIG.

UNSPSC 51291707 Isamoltan is a Commodity code covering pharmaceutical products for opioid overdose response and drug disposal, as reflected in recent state and local solicitations purchasing naloxone and safe drug deactivation systems for community health and public safety programs. State and local governments buying under this code procure naloxone kits and drug deactivation equipment to support harm-reduction and substance-abuse initiatives, typically through health departments, county health authorities, and community-based public health programs. The purchasing pattern shown in recent opportunities reflects a focus on bulk quantities with recurring annual demand and multi-year contract terms, including renewal options, indicating ongoing operational need rather than one-time procurement.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation required electronic bid submission through the county's e-Procurement Portal, included E-Verify and drug-free workplace compliance, and specified a two-year initial term with a one-year renewal option. Based on available recent activity, the code shows limited posting volume; only one opportunity is documented in the dataset.